2014 annual financial data
Aytu BioPharma 2014 Net margin
Direct answer
Net margin was -9,466.8%.
Operating income was -6,346,834 USD and net income was -5,578,690 USD.
Operating cash flow was -5,501,962 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 58,929 USD
- Operating income
- -6,346,834 USD
- Net income
- -5,578,690 USD
- Operating cash flow
- -5,501,962 USD